Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis

Molecular Therapy

Volumn 9, Issue 1, 2004, Pages 46-55

  Rabinovsky, Eric D ^a   Draghia Akli, Ruxandra ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ADViSYS Inc   (United States)

Author keywords

3 untranslated region; Angiogenesis; Diabetes; Electroporation; FLK 1; FLT 1; IGF I; Nerve injury; Plasmid; VEGF

Indexed keywords

ACTIN; ANGIOGENIC FACTOR; CD31 ANTIGEN; HUMAN GROWTH HORMONE; PLASMID DNA; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DOPPLER FLOWMETER; DRUG EFFICACY; ELECTROPORATION; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE THERAPY; IN VIVO STUDY; INTERMETHOD COMPARISON; LEG MUSCLE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NERVE REGENERATION; NONHUMAN; TIBIALIS ANTERIOR MUSCLE;

ANIMALIA;

EID: 1142299561     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.10.003     Document Type: Article

References (57)

1. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31.
2. Horvath, K. A., et al. (2002). Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann. Thoracic Surg. 74: 481-486.
3. Davis, S., et al. (2003). Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10: 38-44.
4. Peters, K. G. (1998). Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ. Res. 83: 342-343.
5. Veikkola, T., Karkkainen, M., Claesson-Welsh, L., and Alitalo, K. (2000). Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60: 203-212.
6. Cheng, H. L., Randolph, A., Yee, D., Delafontaine, P., Tennekoon, G., and Feldman, E. L. (1996). Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J. Neurochem. 66: 525-536.
7. Menetrey, J., et al. (2000). Growth factors improve muscle healing in vivo. J. Bone Joint Surg. Br. 82: 131-137.
8. De Luca, A., Pierno, S., Camerino, C., Cocchi, D., and Camerino, D. C. (1999). Higher content of insulin-like growth factor-I in dystrophic mdx mouse: Potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromusc. Disord. 9: 11-18.
9. Fiorelli, G., et al. (1996). Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18: 269-276.
10. Spoerri, P. E., Ellis, E. A., Tarnuzzer, R. W., and Grant, M. B. (1998). Insulin-like growth factor: Receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth Horm. IGF Res. 8: 125-132.
11. Kobayashi, T., and Kamata, K. (2002). Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 283: H1761-H1768.
12. Punglia, R. S., et al. (1997). Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46: 1619-1626.
13. Akeno, N., Robins, J., Zhang, M., Czyzyk-Krzeska, M. F., and Clemens, T. L. (2002). induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143: 420-425.
14. Miele, C., Rochford, J. J., Filippa, N., Giorgetti-Peraldi, S., and Van Obberghen, E. (2000). Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J. Biol. Chem. 275: 21695-21702.
15. Reinmuth, N., et al. (2002). Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab. Invest. 82: 1377-1389.
16. Wu, Y., Yakar, S., Zhao, L., Hennighausen, L., and LeRoith, D. (2002). Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 62: 1030-1035.
17. Bermont, L., Lamielle, F., Fauconnet, S., Esumi, H., Weisz, A., and Adessi, G. L. (2000). Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. Int. J. Cancer 85: 117-123.
18. Castellon, R., Hamdi, H. K., Sacerio, I., Aoki, A. M., Kenney, M. C., and Ljubimov, A. V. (2002). Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res. 74: 523-535.
19. Shigematsu, S., Yamauchi, K., Nakajima, K., Iijima, S., Aizawa, T., and Hashizume, K. (1999). IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr. J. 46(Suppl.): S59-562.
20. Arthur, W. T., Vernon, R. B., Sage, E. H., and Reed, M. J. (1998). Growth factors reverse the impaired sprouting of microvessels from aged mice. Microvasc. Res. 55: 260-270.
21. Walsh, M. F., Barazi, M., Pete, C., Muniyappa, R., Dunbar, J. C., and Sowers, J. R. (1996). Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide. Endocrinology 137: 1798-1803.
22. Rabinovsky, E. D., et al. (2003). Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 17: 53-55.
23. Jabri, N., et al. (1994). Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes 43: 369-374.
24. Zhuang, H. X., Snyder, C. K, Pu, S. F., and Ishii, D. N. (1996). Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats. Exp. Neurol 140: 198-205.
25. Glazner, G. W., Morrison, A. E., and Ishii, D. N. (1994). Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration. Brain Res. Mol. Brain Res. 25: 265-272.
26. Alila, H., et al. (1997). Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats. Hum. Gene Ther. 8: 1785-1795.
27. Fewell, J. G., et al. (2001). Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol. Ther. 3: 574-583.
28. Draghia-Akli, R., Fiorotto, M. L., Hill, L. A., Malone, P. B., Deaver, D. R., and Schwartz, R. J. (1999). Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs. Nat. Biotechnol. 17: 1179-1183.
29. Draghia-Akli, R., Malone, P. B., Hill, L. A., Ellis, K. M., Schwartz, R. J., and Nordstrom, J. L. (2002). Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J. 16: 426-428.
30. Macchi, P., Hemraj, I., Goetze, B., Grunewald, B., Mallardo, M., and Kiebler, M. A. (2003). A GFP-based system to uncouple mRNA transport from translation in a single living neuron. Mol. Biol. Cell 14: 1570-1582.
31. Gramolini, A. O., Belanger, G., and Jasmin, B. J. (2001). Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells. J. Cell Biol. 154: 1173-1183.
32. Wong, P. M., Yuan, Q., Chen, H., Sultzer, B. M., and Chung, S. W. (2001). A single point mutation at the 3′-untranslated region of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated responses. J. Biol. Chem. 276: 33129-33138.
33. Haas, T. L. (2002). Molecular control of capillary growth in skeletal muscle. Can. J. Appl. Physiol. 27: 491-515.
34. Dimmeler, S., and Zeiher, A. M. (2000). Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87: 434-439.
35. Hang, J., Kong, L., Gu, J. W., and Adair, T. H. (1995). VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am. J. Physiol. 269: H1827-H1831.
36. Gustafsson, T., Puntschart, A., Kaijser, L., Jansson, E., and Sundberg, C. J. (1999). Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am. J. Physiol. 276: H679-H685.
37. Milkiewicz, M., Hudlicka, O., Verhaeg, J., Egginton, S., and Brown, M. D. (2003). Differential expression of Filk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: Favourable effect of muscle activity. Clin. Sci. (London).
38. Hoke, A., Sun, H. S., Gordon, T., and Zochodne, D. W. (2001). Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum. Exp. Neurol. 172: 398-406.
39. Florini, J. R., Ewton, D. Z., and Roof, S. L. (1991). Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5: 718-724.
40. Ishii, D. N., Glazner, G. W., and Pu, S. F. (1994). Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol. Ther. 62: 125-144.
41. Russell, J. W., Cheng, H. L., and Golovoy, D. (2000). Insulin-like growth factor-I promotes myelination of peripheral sensory axons. J. Neuropathol. Exp. Neurol. 59: 575-584.
42. Cheng, H. L., Steinway, M., Delaney, C. L., Franke, T. F., and Feldman, E. L. (2000). IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol. Cell Endocrinol. 170: 211-215.
43. Takahashi, A., et al. (2002). Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol. Cell. Biol. 22: 4803-4814.
44. Gustafsson, T., et al. (2002). Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training. Pflügers Arch. 444: 752-759.
45. Hudlicka, O., Milkiewicz, M., Cotter, M. A., and Brown, M. D. (2002). Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp. Physiol. 87: 373-381.
46. Gille, H., et al. (2001). Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 276: 3222-3230.
47. Autiero, M., Luttun, A., Tjwa, M., and Carmeliet, P. (2003). Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of schemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemostasis 1: 1356-1370.
48. Shibuya, M. (2001). Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int. J. Biochem. Cell Biol. 33: 409-420.
49. Kremer, C., Breier, G., Risau, W., and Plate, K. H. (1997). Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res. 57: 3852-3859.
50. Rivard, A., et al. (1999). Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154: 355-363.
51. Currie, C. J., Morgan, C. L., and Peters, J. R. (1998). The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 21: 42-48.
52. Lorenzi, M., Cagliero, E., and Toledo, S. (1985). Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34: 621-627.
53. Holzenberger, M., et al. (2003). IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187.
54. Wilson, S. H., Davis, M. I., Caballero, S., and Grant, M. B. (2001). Modulation of retinal endothelial cell behavior by insulin-like growth factor I and somatostatin analogues: Implications for diabetic retinopathy. Growth Horm. IGF Res. 11(Suppl. A): S53-S59.
55. Tamatani, M., Ogawa, S., Nunez, G., and Tohyama, M. (1998). Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 5: 911-919.
56. Han, R. N., Post, M., Tanswell, A. K., and Lye, S. J. (2003). Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am. J. Respir. Cell Mol. Biol. 28: 159-169.
57. Coleman, M. E., et al. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270: 12109-12116.